We are kicking off our #AACR26 coverage with ED07. What a fantastic way to start! Session ED07 dives into mechanisms of resistance to targeted & IO therapies, covering RAS inhibitors in lung, colon & pancreatic cancer + checkpoint therapy resistance in head & neck cancers.